Top Markets
#1 SAFEcoin SAFEcoin +32.96%
#2 Zora Zora +29.49%
#3 AI XOVIA AI XOVIA +22.03%
#4 Helium Helium +21.85%
#5 Full Moon Full Moon +19.85%
#6 Merlin's Seal BTC Merlin's Seal BTC +16.10%
#7 0G 0G +15.13%
#8 Axelar Axelar +14.88%
#9 VVS Finance VVS Finance +13.70%
#10 rsERG rsERG +12.24%
Coin of the day
SAFEcoin SAFEcoin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Pozycja w akcjach #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Cena akcji
$22.26
Ostatnia synchronizacja: 2024-03-22
Kapitalizacja rynkowa
$553.40M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Graphite Bio, Inc. (GRPH)

Kategoria

Healthcare
Historia stopy dywidendy dla Graphite Bio, Inc. (GRPH)
Stopa dywidendy (TTM) dla Graphite Bio, Inc. (symbol akcji: GRPH) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Graphite Bio, Inc. (GRPH) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH